These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 26202985)

  • 1. Radiosensitive Hematopoietic Cells Determine the Extent of Skin Inflammation in Experimental Epidermolysis Bullosa Acquisita.
    Iwata H; Witte M; Samavedam UK; Gupta Y; Shimizu A; Ishiko A; Schröder T; Seeger K; Dahlke M; Rades D; Zillikens D; Ludwig RJ
    J Immunol; 2015 Sep; 195(5):1945-54. PubMed ID: 26202985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of antibodies of distinct subclasses and specificity is linked to H2s in an active mouse model of epidermolysis bullosa acquisita.
    Ludwig RJ; Recke A; Bieber K; Müller S; Marques Ade C; Banczyk D; Hirose M; Kasperkiewicz M; Ishii N; Schmidt E; Westermann J; Zillikens D; Ibrahim SM
    J Invest Dermatol; 2011 Jan; 131(1):167-76. PubMed ID: 20720563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The retinoid-related orphan receptor alpha is essential for the end-stage effector phase of experimental epidermolysis bullosa acquisita.
    Sadeghi H; Gupta Y; Möller S; Samavedam UK; Behnen M; Kasprick A; Bieber K; Müller S; Kalies K; de Castro Marques A; Recke A; Schmidt E; Zillikens D; Laskay T; Mariani J; Ibrahim SM; Ludwig RJ
    J Pathol; 2015 Sep; 237(1):111-22. PubMed ID: 25953430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GM-CSF modulates autoantibody production and skin blistering in experimental epidermolysis bullosa acquisita.
    Samavedam UK; Iwata H; Müller S; Schulze FS; Recke A; Schmidt E; Zillikens D; Ludwig RJ
    J Immunol; 2014 Jan; 192(2):559-71. PubMed ID: 24337383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibody-induced intestinal inflammation and weight loss in experimental epidermolysis bullosa acquisita.
    Ishii N; Recke A; Mihai S; Hirose M; Hashimoto T; Zillikens D; Ludwig RJ
    J Pathol; 2011 Jun; 224(2):234-44. PubMed ID: 21381035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fcγ Receptor IIB Controls Skin Inflammation in an Active Model of Epidermolysis Bullosa Acquisita.
    Kovacs B; Tillmann J; Freund LC; Nimmerjahn F; Sadik CD; Bieber K; Ludwig RJ; Karsten CM; Köhl J
    Front Immunol; 2019; 10():3012. PubMed ID: 31993051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement-fixing anti-type VII collagen antibodies are induced in Th1-polarized lymph nodes of epidermolysis bullosa acquisita-susceptible mice.
    Hammers CM; Bieber K; Kalies K; Banczyk D; Ellebrecht CT; Ibrahim SM; Zillikens D; Ludwig RJ; Westermann J
    J Immunol; 2011 Nov; 187(10):5043-50. PubMed ID: 21967893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Model systems duplicating epidermolysis bullosa acquisita: a methodological review.
    Ludwig RJ
    Autoimmunity; 2012 Feb; 45(1):102-10. PubMed ID: 21923614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caspase-1-independent IL-1 release mediates blister formation in autoantibody-induced tissue injury through modulation of endothelial adhesion molecules.
    Sadeghi H; Lockmann A; Hund AC; Samavedam UK; Pipi E; Vafia K; Hauenschild E; Kalies K; Pas HH; Jonkman MF; Iwata H; Recke A; Schön MP; Zillikens D; Schmidt E; Ludwig RJ
    J Immunol; 2015 Apr; 194(8):3656-63. PubMed ID: 25795756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B cells, dendritic cells, and macrophages are required to induce an autoreactive CD4 helper T cell response in experimental epidermolysis bullosa acquisita.
    Iwata H; Bieber K; Tiburzy B; Chrobok N; Kalies K; Shimizu A; Leineweber S; Ishiko A; Vorobyev A; Zillikens D; Köhl J; Westermann J; Seeger K; Manz R; Ludwig RJ
    J Immunol; 2013 Sep; 191(6):2978-88. PubMed ID: 23960233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant human IgA1 and IgA2 autoantibodies to type VII collagen induce subepidermal blistering ex vivo.
    Recke A; Trog LM; Pas HH; Vorobyev A; Abadpour A; Jonkman MF; van Zandbergen G; Kauderer C; Zillikens D; Vidarsson G; Ludwig RJ
    J Immunol; 2014 Aug; 193(4):1600-8. PubMed ID: 25024393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conditional depletion of mast cells has no impact on the severity of experimental epidermolysis bullosa acquisita.
    Kasprick A; Yu X; Scholten J; Hartmann K; Pas HH; Zillikens D; Ludwig RJ; Petersen F
    Eur J Immunol; 2015 May; 45(5):1462-70. PubMed ID: 25678008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Passive transfer of autoantibodies from a patient with mutilating epidermolysis bullosa acquisita induces specific alterations in the skin of neonatal mice.
    Borradori L; Caldwell JB; Briggaman RA; Burr CE; Gammon WR; James WD; Yancey KB
    Arch Dermatol; 1995 May; 131(5):590-5. PubMed ID: 7741548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cells mediate autoantibody-induced cutaneous inflammation and blistering in epidermolysis bullosa acquisita.
    Bieber K; Witte M; Sun S; Hundt JE; Kalies K; Dräger S; Kasprick A; Twelkmeyer T; Manz RA; König P; Köhl J; Zillikens D; Ludwig RJ
    Sci Rep; 2016 Dec; 6():38357. PubMed ID: 27917914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific Inhibition of Complement Activation Significantly Ameliorates Autoimmune Blistering Disease in Mice.
    Mihai S; Hirose M; Wang Y; Thurman JM; Holers VM; Morgan BP; Köhl J; Zillikens D; Ludwig RJ; Nimmerjahn F
    Front Immunol; 2018; 9():535. PubMed ID: 29616034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of epidermolysis bullosa acquisita in mice by passive transfer of autoantibodies from patients.
    Woodley DT; Ram R; Doostan A; Bandyopadhyay P; Huang Y; Remington J; Hou Y; Keene DR; Liu Z; Chen M
    J Invest Dermatol; 2006 Jun; 126(6):1323-30. PubMed ID: 16543893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cells are required for the production of blister-inducing autoantibodies in experimental epidermolysis bullosa acquisita.
    Sitaru AG; Sesarman A; Mihai S; Chiriac MT; Zillikens D; Hultman P; Solbach W; Sitaru C
    J Immunol; 2010 Feb; 184(3):1596-603. PubMed ID: 20038644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid.
    Shimanovich I; Mihai S; Oostingh GJ; Ilenchuk TT; Bröcker EB; Opdenakker G; Zillikens D; Sitaru C
    J Pathol; 2004 Dec; 204(5):519-27. PubMed ID: 15538734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of interferon gamma impairs induction of experimental epidermolysis bullosa acquisita.
    Gross N; Marketon J; Mousavi S; Kalies K; Ludwig RJ; Bieber K
    Front Immunol; 2024; 15():1343299. PubMed ID: 38799441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for a contributory role of a xenogeneic immune response in experimental epidermolysis bullosa acquisita.
    Niebuhr M; Kasperkiewicz M; Maass S; Hauenschild E; Bieber K; Ludwig RJ; Westermann J; Kalies K
    Exp Dermatol; 2017 Dec; 26(12):1207-1213. PubMed ID: 28887841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.